Fairmount Funds Management LLC bought APGE
January 29, 2024 · Form 4 insider transaction
Fairmount Funds Management LLC bought 51,166 shares of Apogee Therapeutics Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as j under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
51,166
Price
$0.00
Total value
N/A
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeJ: J
Transaction dateJanuary 29, 2024
Filing dateJanuary 31, 2024
Shares owned after51,166
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP ("Co-Invest") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023.